Evidence map›Paper›PMID 34794443›Full record

ArticleBiomedical engineering online2021

Fus2Net: a novel Convolutional Neural Network for classification of benign and malignant breast tumor in ultrasound images.

He Ma, Ronghui Tian, Hong Li, Hang Sun, Guoxiu Lu, Ruibo Liu, Zhiguo Wang

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

He MaCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, 110169, China.
Ronghui TianCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, 110169, China.
Hong LiCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, 110169, China.
Hang SunCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, 110169, China.
Guoxiu LuCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, 110169, China.
Ruibo LiuCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, 110169, China.
Zhiguo WangDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenhe District, Shenyang, Liaoning, 110016, China. wangzhiguo5778@163.com.
Northeastern University · CNGeneral Hospital of Shenyang Military Region · CNMinistry of Education of the People's Republic of China · CN

Funding

the Guizhou Province Science and Technology Project under Grant Qiankehezhicheng[2019] 2794the key Research and Development Program of Liaoning Province 2019JH2/10300010
6 · The paper itself

Abstract

backgroundThe rapid development of artificial intelligence technology has improved the capability of automatic breast cancer diagnosis, compared to traditional machine learning methods. Convolutional Neural Network (CNN) can automatically select high efficiency features, which helps to improve the level of computer-aided diagnosis (CAD). It can improve the performance of distinguishing benign and malignant breast ultrasound (BUS) tumor images, making rapid breast tumor screening possible.

resultsThe classification model was evaluated with a different dataset of 100 BUS tumor images (50 benign cases and 50 malignant cases), which was not used in network training. Evaluation indicators include accuracy, sensitivity, specificity, and area under curve (AUC) value. The results in the Fus2Net model had an accuracy of 92%, the sensitivity reached 95.65%, the specificity reached 88.89%, and the AUC value reached 0.97 for classifying BUS tumor images.

conclusionsThe experiment compared the existing CNN-categorized architecture, and the Fus2Net architecture we customed has more advantages in a comprehensive performance. The obtained results demonstrated that the Fus2Net classification method we proposed can better assist radiologists in the diagnosis of benign and malignant BUS tumor images.

methodsThe existing public datasets are small and the amount of data suffer from the balance issue. In this paper, we provide a relatively larger dataset with a total of 1052 ultrasound images, including 696 benign images and 356 malignant images, which were collected from a local hospital. We proposed a novel CNN named Fus2Net for the benign and malignant classification of BUS tumor images and it contains two self-designed feature extraction modules. To evaluate how the classifier generalizes on the experimental dataset, we employed the training set (646 benign cases and 306 malignant cases) for tenfold cross-validation. Meanwhile, to solve the balance of the dataset, the training data were augmented before being fed into the Fus2Net. In the experiment, we used hyperparameter fine-tuning and regularization technology to make the Fus2Net convergence.

Indexed as

Artificial IntelligenceBreast NeoplasmsFemaleHumansMachine LearningNeural Networks, ComputerUltrasonography, MammaryBreast ultrasound tumor imagesClassificationConvolutional Neural NetworkData augmentationDeep learning

Identifiers

PMID34794443
PMCPMC8600702
OpenAlexW3201518537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.